Innovation is one of our strategic and fundamental pillars, permeating every level of our company. We continuously innovate across biomaterials, assays, and biotechnology manufacturing processes. We aim to enhance our expertise in immunoassays and technological capabilities, ultimately increasing efficiency and robustness, reducing time to market, and streamlining operations.
Within Werfen culture, we embrace, promote, and leverage a distinctive network comprising scientists, entrepreneurs, and key players in the IVD sector. This network enables us to identify and integrate the most cutting-edge tools and technologies.
 

We work towards moving your immunoassay portfolio one step beyond  

Our Approach

During the initial stages of developing a new immunoassay, selecting the appropriate biomaterials and defining the formulation efficiently and promptly is crucial. This helps mitigate risks in later stages of the project, where substantial commitments are made, and delays in product launch could incur additional costs